*This is not a complete list of medications used for chronic obstructive pulmonary disease (COPD). † This is the only formulation of this specific combination of drugs approved by the Food and Drug Administration for tre...
Despite this, COPD treatment and its management are mainly based on lung function assessments. There is increasing evidence that conventional lung function measures alone do not correlate well with COPD symptoms and their associated impact on patients' everyday lives. Instead, symptoms should...
A gap exists between guidelines and real-world clinical practice for the management and treatment of chronic obstructive pulmonary disease (COPD). Although this has narrowed in the last decade, there is room for improvement in detection rates, treatment choices and disease monitoring. In practical te...
Published estimates for the treatment costs of breast cancer vary widely in methodology, perspective, patient populations and time horizon. We systematical... JD Campbell,DSD Ramsey - 《Pharmacoeconomics》 被引量: 125发表: 2009年 A UK-Based Cost-Utility Analysis of Indacaterol, A Once-Daily Mainte...
the progressive decline of pulmonary function, the real goals of COPD management are: prevention (e. g. stop smoking), early diagnosis, and treatment ... M Zamparella,P Scalera,F Anelli 被引量: 0发表: 2017年 加载更多来源期刊 Australian family physician 2010/03/01 研究点推荐 COPD Chronic...
Cardiopulmonary rehabilitation helps improve the well-being of patients with COPD. This is a team approach and may include dietitians, doctors, exercise specialists, nurses, physical therapists, and respiratory therapists. The goal of cardiopulmonary rehabilitation is to bring disease management training, ...
and long-acting beta(2)-adrenoceptor agonist single-inhaler combination for both maintenanceand rescue therapy:A paradigm shift in asthma management. Treat... DAD D’Urzo - 《Treatments in Respiratory Medicine》 被引量: 54发表: 2006年 Clinical Safety of Long-Acting β 2 -Agonist and Inhaled Co...
CHENYahong. Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2022 Report. Chinese General Practice[J], 2022, 25(11): 1294-1304,1308 doi:10.12114/j.issn.1007-9572.2022.01.302 ...
[2]Martin A, Badrick E, Mathur R, et al. Effect ofethnicity on the prevalence, severity, and management of COPD in general practice. Br J Gen Pract 2012;62(595):e76- 81 [3]Wedzicha JA, Zhong N, Ichinose M, et al. Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian pati...
[6] Yang IA, Brown JL,COPD-X Australian and NewZealand guidelines for the diagnosis and management of chronic obstructivepulmonary disease: 2017 update[J]Med. Aust. 2017 Nov 20;207(10):436-442 [7] Stolz D, Barandun J, Borer H, Diagnosis,Prevention and Treatment of Stable COPD and Acute...